First Trust NYSE Arca Biotechnology Index Fund (NYSEARCA:FBT) Short Interest Update

First Trust NYSE Arca Biotechnology Index Fund (NYSEARCA:FBT) saw a significant increase in short interest in April. As of April 30th, there was short interest totaling 35,295 shares, an increase of 79.8% from the April 15th total of 19,633 shares. Currently, 0.3% of the shares of the stock are sold short. Based on an average daily volume of 53,486 shares, the days-to-cover ratio is currently 0.7 days.

Hedge Funds Weigh In On First Trust NYSE Arca Biotechnology Index Fund

Institutional investors and hedge funds have recently bought and sold shares of the business. High Point Wealth Management LLC acquired a new position in shares of First Trust NYSE Arca Biotechnology Index Fund during the fourth quarter valued at $26,000. AG Campbell Advisory LLC bought a new stake in First Trust NYSE Arca Biotechnology Index Fund in the fourth quarter valued at about $31,000. Russell Investments Group Ltd. increased its holdings in First Trust NYSE Arca Biotechnology Index Fund by 7,900.0% in the third quarter. Russell Investments Group Ltd. now owns 160 shares of the company’s stock valued at $29,000 after purchasing an additional 158 shares during the last quarter. Rossby Financial LCC increased its holdings in First Trust NYSE Arca Biotechnology Index Fund by 160.0% in the third quarter. Rossby Financial LCC now owns 169 shares of the company’s stock valued at $31,000 after purchasing an additional 104 shares during the last quarter. Finally, Cassaday & Co Wealth Management LLC bought a new stake in First Trust NYSE Arca Biotechnology Index Fund in the first quarter valued at about $34,000.

First Trust NYSE Arca Biotechnology Index Fund Stock Performance

First Trust NYSE Arca Biotechnology Index Fund stock opened at $206.89 on Monday. The firm has a market cap of $2.34 billion, a P/E ratio of 21.72 and a beta of 0.66. The business’s fifty day moving average is $202.28 and its two-hundred day moving average is $206.34. First Trust NYSE Arca Biotechnology Index Fund has a 52 week low of $156.63 and a 52 week high of $224.94.

About First Trust NYSE Arca Biotechnology Index Fund

The First Trust NYSE Arca Biotechnology Index Fund (FBT) is an exchange-traded fund that is based on the NYSE Arca Biotechnology index. The fund tracks an equal-weighted index of US biotechnology stocks. FBT was launched on Jun 19, 2006 and is managed by First Trust.